Showing results (161-170 of 322) with videos related to

Sort By:
Pageof 33
British Journal of Pharmacology|October 1, 1995
Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heartP Chatelain, L Meysmans, J R Mattéazzi, et al.
European Journal of Pharmacology|August 15, 1993
In vitro characterization of a novel Ca2+ entry blocker: SR 33805P Chatelain, M Clinet, P Polster, et al.
Cell Biology International Reports|April 1, 1981
Effect of serum concentration on the chromosome number of a rat liver epithelial cell lineM Chessebeuf, M F Exilie, G Piard, et al.
European Heart Journal|August 1, 1987
Digital videodensitometric measurement of aortic regurgitationJ Divernois, P Chatelain, P A Doriot, et al.
Cardiovascular Research|December 1, 1995
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blockerP Chatelain, J Mouton, G Feys, et al.
Diabetes & Metabolism|July 1, 1996
Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGF1 treatmentJ C Carel, J L Chaussain, P Chatelain, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1995
Stenting with the half (disarticulated) Palmaz-Schatz stentV K Mehan, U Kaufmann, P Urban, et al.
European Journal of Pharmacology|July 22, 1983
Increased number of high-affinity muscarinic receptors in rat heart after phenylhydrazine treatmentP Chatelain, M Waelbroeck, P De Neef, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studiesP Polster, B Christophe, M Van Damme, et al.
The Pharmacogenomics Journal|October 28, 2015
Effect of summer daylight exposure and genetic background on growth in growth hormone-deficient childrenC De Leonibus, P Chatelain, C Knight, et al.
Pageof 33